These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 20401664)

  • 1. Differential beta-catenin expression between glottic and supraglottic laryngeal carcinoma.
    Goulioumis AK; Varakis J; Goumas P; Papadaki H
    Eur Arch Otorhinolaryngol; 2010 Oct; 267(10):1573-8. PubMed ID: 20401664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct Biomarker Profiles and Clinical Characteristics in T1-T2 Glottic and Supraglottic Carcinomas.
    Wachters JE; Kop E; Slagter-Menkema L; Mastik M; van der Wal JE; van der Vegt B; de Bock GH; van der Laan BFAM; Schuuring E
    Laryngoscope; 2020 Dec; 130(12):2825-2832. PubMed ID: 32065407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cadherin-catenin complex in laryngeal squamous cell carcinoma.
    Galera-Ruiz H; Ríos-Moreno MJ; González-Cámpora R; Ortega I; Fernández A; García-Escudero A; Galera-Davidson H
    Eur Arch Otorhinolaryngol; 2012 Apr; 269(4):1183-8. PubMed ID: 22197995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrin-linked kinase cytoplasmic and nuclear expression in laryngeal carcinomas.
    Goulioumis AK; Bravou V; Varakis J; Goumas P; Papadaki H
    Virchows Arch; 2008 Nov; 453(5):511-9. PubMed ID: 18813944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen receptor-beta expression in human laryngeal carcinoma: correlation with the expression of epithelial-mesenchymal transition specific biomarkers.
    Goulioumis AK; Fuxe J; Varakis J; Repanti M; Goumas P; Papadaki H
    Oncol Rep; 2009 Nov; 22(5):1063-8. PubMed ID: 19787222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supraglottic and glottic carcinomas. clinically and biologically distinct entities?
    Hirvikoski P; Virtaniemi J; Kumpulainen E; Johansson R; Kosma VM
    Eur J Cancer; 2002 Sep; 38(13):1717-23. PubMed ID: 12175687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glottic and supraglottic pT3 squamous cell carcinoma: outcomes with transoral laser microsurgery.
    Pantazis D; Liapi G; Kostarelos D; Kyriazis G; Pantazis TL; Riga M
    Eur Arch Otorhinolaryngol; 2015 Aug; 272(8):1983-90. PubMed ID: 25821031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of epithelial-to-mesenchymal transition in laryngeal carcinoma: Its role in the different subsites.
    Mezi S; Chiappetta C; Carletti R; Nardini A; Cortesi E; Orsi E; Piesco G; Di Gioia C
    Head Neck; 2017 Sep; 39(9):1806-1818. PubMed ID: 28561907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reconsidering a paradigm: the spread of supraglottic carcinoma to the glottis.
    Weinstein GS; Laccourreye O; Brasnu D; Tucker J; Montone K
    Laryngoscope; 1995 Oct; 105(10):1129-33. PubMed ID: 7564847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glottic versus supraglottic tumors: differential molecular profile.
    Kourelis K; Papadas T; Vandoros G; Goumas P; Sotiropoulou-Bonikou G
    Eur Arch Otorhinolaryngol; 2008 Jan; 265(1):79-84. PubMed ID: 17909831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of E-cadherin, N-cadherin, β-catenin and their clinical significance in laryngeal carcinoma].
    Song PP; Qian XY; Zhou H; Shen XH; Liu DD; Feng AN; Gao X
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jun; 51(6):440-5. PubMed ID: 27345880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ki-67, p-53, E-Cadherin, and β-Catenin expression of advanced glotto-subglottic and supraglottic larynx carcinomas.
    Kara A; Turan G; Guven M; Guven EM; Elden H
    Niger J Clin Pract; 2022 Sep; 25(9):1424-1429. PubMed ID: 36149200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E-cadherin, β-catenin and Snail immunoexpression in laryngeal squamous cell carcinoma.
    Cercelaru L; Stepan AE; Mărgăritescu C; Osman A; Popa IC; Florescu MM; Simionescu CE; Mărgăritescu OC
    Rom J Morphol Embryol; 2017; 58(3):761-766. PubMed ID: 29250652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of intrinsic hypoxia markers HIF1alpha and CA-IX predict for local recurrence in stage T1-T2 glottic laryngeal carcinoma treated with radiotherapy.
    Schrijvers ML; van der Laan BF; de Bock GH; Pattje WJ; Mastik MF; Menkema L; Langendijk JA; Kluin PM; Schuuring E; van der Wal JE
    Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):161-9. PubMed ID: 18722267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glottic and supraglottic laryngeal carcinoma: differences in epidemiology, clinical characteristics and prognosis.
    Raitiola H; Pukander J; Laippala P
    Acta Otolaryngol; 1999; 119(7):847-51. PubMed ID: 10687946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of early glottic and supraglottic carcinoma treated with conventional fractionation of radiotherapy.
    Inoue T; Inoue T; Ikeda H; Teshima T; Yamazaki H; Murayama S; Othani M; Ozeki S
    Strahlenther Onkol; 1993 Oct; 169(10):584-9. PubMed ID: 8235982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative study of histology and flow cytometry results obtained in 2 groups of laryngeal tumors, glottic and supraglottic, in T-1 stage].
    Barona R; Martorell MA; Basterra J; Garín L; Armengot M
    Acta Otorrinolaringol Esp; 1992; 43(6):401-6. PubMed ID: 1299280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of lymphangiogenesis in supraglottic laryngeal carcinoma.
    Lin JY; Li XY; Dong P; Nakashima T
    J Laryngol Otol; 2011 Sep; 125(9):945-51. PubMed ID: 21774849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of E-cadherin in squamous cell carcinomas of the supraglottic larynx with correlations to clinicopathological features.
    Rodrigo JP; Domínguez F; Alvarez C; Manrique C; Herrero A; Suárez C
    Eur J Cancer; 2002 May; 38(8):1059-64. PubMed ID: 12008193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From laryngeal epithelial precursor lesions to squamous carcinoma of the larynx: the role of cell cycle proteins and β-catenin.
    López F; Alvarez-Marcos C; Alonso-Guervós M; Domínguez F; Suárez C; Hermsen MA; Llorente JL
    Eur Arch Otorhinolaryngol; 2013 Nov; 270(12):3153-62. PubMed ID: 23564160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.